Get a glimpse into our company and investor data—powered by the PitchBook Platform
A right for the development of pharmaceutical products. The asset comprises of worldwide rights to the immuno-therapeutic cancer, allergy and infectious disease clinical programs of MannKind.
This information is reserved for PitchBook Platform users. To explore MannKind (Clinical Program Rights)‘s full profile, request access.
© 2020 PitchBook Data. All rights reserved. PitchBook is a financial technology company that provides data on the capital markets.